浙江仙琚制药股份有限公司-我们的产品

CN

Xianju

CN

Xianju

Index
About Xianju

Into Xianju Company Culture Contact Us
Our Products

FDFs API & INTERMEDIATES CDMO & CMO
R&D and Innovation

Innovation Dynamics R&D Pipeline Innovation Platform R&D Introduction
Investor Relations

Stock Info Investor Contact
Social Responsibility

ESG sustain development

Search

Search Results

Product Search(29) News Search(67)

Zhejiang Xianju Pharmaceutical Co., Ltd. Announcement on Obtaining the Domestic Production Drug Registration Certificate for Beraprost Sodium Tablets

2025.03.21
Flumazenil Injection of XIANJU PHARMA passed consistency evaluation

2022.01.11
XIANJU PHARMA obtained the registration certificate for domestic production of Methylprednisolone Tablets

2021.10.30
Ropivacaine Hydrochloride Injection of XIANJU PHARMA passed consistency evaluation

2021.06.02
Finasteride Tablets of XIANJU PHARMA passed consistency evaluation

2021.03.09
Finasteride Tablets of XIANJU PHARMA passed consistency evaluation

2021.01.22

首页
1
2
…
9
10
11
12
末页
跳至页
GO

More